Ebrahim Eini
Impact in
-
- Air Quality and Health Impacts
- Climate Change and Health Impacts
-
- Blood Pressure and Hypertension Studies
Papers in
- Health 1
- Vaccine Coverage and Hesitancy 1
-
- Pulmonary Hypertension Research and Treatments 1
- Chronic Obstructive Pulmonary Disease (COPD) Research 1
Ebrahim Eini
18 papers receiving 10.0k citations
Ebrahim Eini's Hit Papers
Peers
Comparison fields: 5 of 183
- Health, Toxicology and Mutagenesis 716
- Cardiology and Cardiovascular Medicine 576
- Otorhinolaryngology 107
- Epidemiology 811
- Nephrology 166
Countries citing papers authored by Ebrahim Eini
This map shows the geographic impact of Ebrahim Eini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebrahim Eini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebrahim Eini more than expected).
Fields of papers citing papers by Ebrahim Eini
This network shows the impact of papers produced by Ebrahim Eini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebrahim Eini. The network helps show where Ebrahim Eini may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 2 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1647 |
| 3 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1622 |
| 4 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 912 |
| 5 | The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 680 |
| 6 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 650 |
| 7 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 642 |
| 8 | Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 484 |
| 9 | Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 213 |
| 10 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 170 |
| 11 | Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 128 |
| 12 | 2023 | 65 | |
| 13 | Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 52 |
| 14 | 2022 | 51 | |
| 15 | Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 35 |
| 16 | 2024 | 28 | |
| 17 | 2024 | 18 | |
| 18 | 2025 | 5 | |
| 19 | Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 | 2025 | 0 |
About Ebrahim Eini
Ebrahim Eini is a scholar working on Health, Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 10.3k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (1 paper), Cardiac Imaging and Diagnostics (1 paper), Injury Epidemiology and Prevention (1 paper), Pulmonary Hypertension Research and Treatments (1 paper), Respiratory viral infections research (1 paper), Global Maternal and Child Health (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper) and Air Quality and Health Impacts (1 paper). The work is most often cited by research in Health, Toxicology and Mutagenesis (716 citations), Cardiology and Cardiovascular Medicine (576 citations), Otorhinolaryngology (107 citations), Epidemiology (811 citations) and Nephrology (166 citations). Ebrahim Eini has collaborated with scholars based in United States, Iran and Canada. Their work appears in journals such as The Lancet, The Lancet Infectious Diseases, EClinicalMedicine, The Lancet Planetary Health and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.